Medi Monster

Medi Monster — Investor Access

Enter the personal access code from your invitation.

That code wasn't recognized. Please check your invitation.
Confidential. For invited prospective investors only.
First-time access requires accepting the confidentiality agreement. Not an offer to sell securities.
Medi Monster Confidential
Investor Portal · Seattle, WA

Outdoor-adapted cannabis genetics,
built on real data.

Medi Monster, Inc. is a boutique cannabis genetics and cultivation-R&D company developing resilient, high-terpene cultivars for Pacific-Northwest outdoor conditions — selected through environmental stress testing, plant-level data, and repeatable operating systems.

Raising $500,000 Convertible note $4M cap 20% discount 4% · 24 mo
Express interest View data room
Confidential. Investor-safe summary for invited prospective investors who have accepted the confidentiality agreement. Not an offer to sell or a solicitation to buy securities. Draft, non-binding terms. No trade-secret formulas are disclosed in this portal.
The opportunity

Modern cultivars are built for indoor rooms — not real outdoor weather.

Most commercially available cannabis genetics are optimized for controlled indoor production and frequently underperform outdoors in the Pacific Northwest, where humidity, rain, wind, temperature swings, pests, and mold pressure expose weak phenotypes.

Underserved niche

Regionally adapted, mold-resistant, high-terpene outdoor genetics are scarce — and in growing demand.

Rising home & boutique demand

Interest in home cultivation, autoflower lines, and boutique seed markets supports long-term demand.

Data is the moat

Documented, repeatable performance under real stress is rare — and compounds into defensible IP.

Approach & current program

A disciplined, round-based R&D engine on a real rooftop.

  • Round-based evaluation (1.1 / 1.2 / 1.3) feeding internal seed generation (Round 2).
  • Plant-level logging: watering, pH, nutrition, nodes, stress, IPM, and performance.
  • Selection criteria: resilience, recovery rate, structure, and terpene performance under outdoor conditions.
  • Staggered, modular cultivation that keeps overhead low and data clean.

Current program — Round 1.3

Seattle 98116 rooftop outdoor test environment, 5-gallon fabric pots, standardized media. Summer focus on Bruce Banner Auto and Sour Apple Auto (staggered ~10 plants/month). Cold-season candidates reserved: Tropicana Cookies and Cherry Pie OG.

Live · running now
Product ecosystem

From genetics to a branded, data-backed cultivation platform.

Medi Monster has expanded from a genetics-only concept into a full cultivation product ecosystem — genetics, rooftop R&D, sensor-backed data, proprietary grow inputs, and accessory products aimed at a smoother, more repeatable experience. Exact formulas are protected as trade secrets and excluded here.

HatchLab

All-in-one germination station: integrated warmth, humidity dome, gentle light, bottom-wicking hydration, push-release cells.

Concept locked · design R&D

SmoothFinish

All-in-one flower-finishing system designed to support the late-flower window. Trade-secret method under development.

Flagship · prototype R&D

RootSpark · Pixie Bloom

Separate microbial root-zone and terpene-forward signal fractions used in the finishing system.

Formula protected

Lava Soil + Plugs

Starter plugs and base-media system supporting the germination-to-transplant workflow.

Prototype lane

Smoothness Index

A proof layer that converts subjective flower/draw comfort into repeatable, test-backed data.

R&D framework

SmoothDraw Filter Tips

Premium activated-carbon/fiber-style joint & pre-roll accessory focused on draw comfort, airflow, and dust control.

New product lane
Monster Command — the software layer

An operating system for the grow, built in-house.

Monster Command turns the rooftop program into structured, sensor-backed data: live environmental telemetry, camera snapshots, plant-level tracking, irrigation and IPM logging, a seed/genetics registry, and an AI grow assistant. It's the system that makes the genetics data repeatable — and the long-term performance dataset defensible.

Live
Ecowitt sensor telemetry
Plant-level
tracking & lineage
In-house
Next.js · Supabase build
Why Medi Monster

Competitive advantages

  • Pacific-Northwest outdoor adaptation focus
  • Real-world rooftop environmental testing
  • Stress-tested phenotype selection
  • Data-backed cultivation methodologies + in-house software
  • Low-overhead, modular operational scaling
  • Genetics-centered intellectual-property strategy
Commercial path

Phased toward proprietary genetics & IP.

1
R&D & keeper selection.
Round-based evaluation and stress-tested phenotype selection on the rooftop.
2
Internal seed generation & stabilization.
Controlled feminized breeding of selected keepers into repeatable lines.
3
Seed / clone licensing & releases.
Commercial releases plus grow inputs and accessories. Long-term value: proprietary genetics + documented performance data (IP).
Revenue opportunities

Feminized & autoflower seed lines

Clone sales & nursery operations

Genetics licensing

Grow inputs & accessories

Cultivation education & branded content

Research & adaptation consulting

The round

$500,000 convertible note (draft terms)

InstrumentConvertible note
Raise target$500,000
Interest4%
Maturity24 months
Valuation cap$4,000,000
Discount20%
Qualified-financing trigger~$1,000,000+
Governing lawWashington
Investor obligationsConfidentiality & non-interference; respect for trade-secret material
Use of funds
  • R&D scaling: propagation, monitoring, IPM, documentation systems
  • Prototype materials, ingredient testing, formulation equipment & QA
  • HatchLab design, packaging samples, product photography & branding
  • Sensor-backed cultivation trials & controlled product comparisons
  • Third-party lab testing where appropriate
  • Legal: entity & investor documents, trademarks, provisional-patent strategy, compliance
  • Pre-commercial facility planning
Traction & capital efficiency

Bootstrapped, licensed, and already running.

~$5.7K
founder capital deployed to date
3
WA entities formed & structured
Round 1.3
rooftop program live
  • Entities formed with WA Secretary of State (holdco + operating structure)
  • WA endorsements obtained: Cannabis Research, Transportation, Seed Dealer, Nursery Retail Plant Seller
  • Monster Command software built in-house and in daily use
  • Foundational cultivation, IPM, and feminized-breeding workflows established
Structure & team

Clean holding structure, founder-led.

Evergreen Capital Group, LLC

Holding company.

Cannabis Genetics, LLC

Genetics & R&D entity (trade name: Medi Monster, Inc.).

Medi Monster, Inc.

Operating / brand entity. All operational expenses flow here.

Founder & operator: Boback Ilami — leading genetics, rooftop R&D, and the in-house Monster Command software, with design/packaging support.

Data room

Documents

Investor-safe materials. Exact formulas, batch records, and manufacturing methods remain in a separate, NDA-gated formula workbook and are not included here.

Loading secure documents…

How to invest

From interest to funded — five steps.

This round is a $500,000 convertible note (terms above). The note and subscription agreement are executed with our counsel, and funding instructions are shared securely at signing — never by email or through this portal.

1
Review.
Read the terms and the data room on this page.
2
Confidentiality.
Done — you accepted the agreement on entry.
3
Indicate interest.
Tell us your intended amount; we send the convertible note & subscription agreement.
4
Sign.
Execute the note and subscription agreement electronically with our counsel.
5
Fund.
Wire per the signed note; closing instructions are provided securely at signing.
Indicate intent to invest →
Next step

Let's talk.

Request the full diligence package, schedule a rooftop walkthrough, or ask about the note.

Express interest